Quantum BioPharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	0.45	6	2.76	16.98	35.26	17.52
Short-Term Investments	0.64	1.2	0.76	-	0.16	-
Cash & Short-Term Investments	1.08	7.2	3.51	16.98	35.42	17.52
Cash Growth	-83.61%	104.89%	-79.31%	-52.06%	102.10%	193.66%
Accounts Receivable	2.86	3.43	7.19	0.02	-	-
Other Receivables	0.08	0.37	0.23	0.37	0.5	0.16
Receivables	2.94	3.81	7.42	0.4	0.5	0.16
Inventory	0.08	0.12	-	-	-	-
Prepaid Expenses	0.04	0.04	0.12	0.16	0.76	0.57
Other Current Assets	5.21	0.89	0.03	0.31	9.25	8.61
Total Current Assets	9.34	12.05	11.09	17.85	45.93	26.87
Property, Plant & Equipment	0.19	0.13	0.12	0.26	0.17	-
Long-Term Investments	-	0	0.01	0.83	0.66	1.68
Other Intangible Assets	4.62	4.93	5.36	12.04	16.2	13.42
Long-Term Accounts Receivable	-	-	0.91	7.43	-	-
Total Assets	14.15	17.12	17.47	38.41	62.96	41.97
Accounts Payable	2.61	3.25	3.24	2.76	3	2.06
Accrued Expenses	1.48	1.11	0.95	4.35	4.46	1.62
Short-Term Debt	1.98	0.62	0.3	0.3	0.3	0.38
Current Portion of Long-Term Debt	0.43	0.15	-	-	-	-
Current Portion of Leases	0.15	0.05	0.04	0.18	0.12	0.05
Current Unearned Revenue	-	1	-	-	-	-
Other Current Liabilities	0	0.49	0.03	0.24	0.83	1.46
Total Current Liabilities	6.65	6.68	4.57	7.83	8.7	5.58
Long-Term Leases	-	-	-	0.04	0.13	0.08
Total Liabilities	6.65	6.68	4.57	7.87	8.83	5.66
Common Stock	169.03	150.47	137.78	143.41	152.32	103.21
Additional Paid-In Capital	33.58	31.07	30.23	28.5	22.58	18.79
Retained Earnings	-195.26	-172.11	-157.91	-144.16	-126.15	-90.87
Comprehensive Income & Other	1.3	2.05	3.14	2.8	5.38	5.18
Total Common Equity	8.65	11.48	13.24	30.54	54.13	36.31
Minority Interest	-1.15	-1.04	-0.33	-	-	-
Shareholders' Equity	7.51	10.44	12.91	30.54	54.13	36.31
Total Liabilities & Equity	14.15	17.12	17.47	38.41	62.96	41.97
Total Debt	2.56	0.82	0.34	0.52	0.56	0.51
Net Cash (Debt)	-1.47	6.37	3.17	16.46	34.86	17.01
Net Cash Growth	-	100.80%	-80.72%	-52.77%	104.90%	288.50%
Net Cash Per Share	-0.52	5.61	5.21	27.63	64.84	91.82
Filing Date Shares Outstanding	3.82	2.71	0.62	0.63	0.59	0.54
Total Common Shares Outstanding	3.82	2.3	0.61	0.59	0.62	0.29
Working Capital	2.7	5.37	6.52	10.02	37.23	21.29
Book Value Per Share	2.27	4.99	21.85	51.56	86.98	123.17
Tangible Book Value	4.03	6.55	7.88	18.5	37.93	22.88
Tangible Book Value Per Share	1.06	2.85	13.01	31.23	60.95	77.63

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q